177 related articles for article (PubMed ID: 32606444)
1. Benefit of diverse surgical approach on short-term outcomes of MEN1-related hyperparathyroidism.
Choi HR; Choi SH; Choi SM; Kim JK; Lee CR; Kang SW; Lee J; Jeong JJ; Nam KH; Chung WY; Lee S; Hong N; Rhee Y
Sci Rep; 2020 Jun; 10(1):10634. PubMed ID: 32606444
[TBL] [Abstract][Full Text] [Related]
2. Long-Term Surveillance of Treated Hyperparathyroidism for Multiple Endocrine Neoplasia Type 1: Recurrence or Hypoparathyroidism?
Fyrsten E; Norlén O; Hessman O; Stålberg P; Hellman P
World J Surg; 2016 Mar; 40(3):615-21. PubMed ID: 26541865
[TBL] [Abstract][Full Text] [Related]
3. Single gland excision for MEN1-associated primary hyperparathyroidism.
Manoharan J; Albers MB; Bollmann C; Maurer E; Mintziras I; Wächter S; Bartsch DK
Clin Endocrinol (Oxf); 2020 Jan; 92(1):63-70. PubMed ID: 31626728
[TBL] [Abstract][Full Text] [Related]
4. The optimal surgical treatment for primary hyperparathyroidism in MEN1 patients: a systematic review.
Schreinemakers JM; Pieterman CR; Scholten A; Vriens MR; Valk GD; Rinkes IH
World J Surg; 2011 Sep; 35(9):1993-2005. PubMed ID: 21713580
[TBL] [Abstract][Full Text] [Related]
5. Primary hyperparathyroidism in MEN1 patients: a cohort study with longterm follow-up on preferred surgical procedure and the relation with genotype.
Pieterman CR; van Hulsteijn LT; den Heijer M; van der Luijt RB; Bonenkamp JJ; Hermus AR; Borel Rinkes IH; Vriens MR; Valk GD;
Ann Surg; 2012 Jun; 255(6):1171-8. PubMed ID: 22470073
[TBL] [Abstract][Full Text] [Related]
6. Unilateral Clearance for Primary Hyperparathyroidism in Selected Patients with Multiple Endocrine Neoplasia Type 1.
Kluijfhout WP; Beninato T; Drake FT; Vriens MR; Gosnell J; Shen WT; Suh I; Liu C; Duh QY
World J Surg; 2016 Dec; 40(12):2964-2969. PubMed ID: 27402205
[TBL] [Abstract][Full Text] [Related]
7. Optimal extent of initial parathyroid resection in patients with multiple endocrine neoplasia syndrome type 1: A meta-analysis.
Nastos C; Papaconstantinou D; Kofopoulos-Lymperis E; Peppa M; Pikoulis A; Lykoudis P; Palazzo F; Patapis P; Pikoulis E
Surgery; 2021 Feb; 169(2):302-310. PubMed ID: 33008613
[TBL] [Abstract][Full Text] [Related]
8. Less Than Subtotal Parathyroidectomy for Multiple Endocrine Neoplasia Type 1 Primary Hyperparathyroidism: A Systematic Review and Meta-Analysis.
Bouriez D; Gronnier C; Haissaguerre M; Tabarin A; Najah H
World J Surg; 2022 Nov; 46(11):2666-2675. PubMed ID: 35767091
[TBL] [Abstract][Full Text] [Related]
9. Primary and reoperative parathyroid operations in hyperparathyroidism of multiple endocrine neoplasia type 1.
Hellman P; Skogseid B; Oberg K; Juhlin C; Akerström G; Rastad J
Surgery; 1998 Dec; 124(6):993-9. PubMed ID: 9854574
[TBL] [Abstract][Full Text] [Related]
10. Limited Parathyroidectomy in Multiple Endocrine Neoplasia Type 1-Associated Primary Hyperparathyroidism: A Setup for Failure.
Nilubol N; Weinstein LS; Simonds WF; Jensen RT; Marx SJ; Kebebew E
Ann Surg Oncol; 2016 Feb; 23(2):416-23. PubMed ID: 26542588
[TBL] [Abstract][Full Text] [Related]
11. Is total parathyroidectomy the treatment of choice for hyperparathyroidism in multiple endocrine neoplasia type 1?
Tonelli F; Marcucci T; Fratini G; Tommasi MS; Falchetti A; Brandi ML
Ann Surg; 2007 Dec; 246(6):1075-82. PubMed ID: 18043113
[TBL] [Abstract][Full Text] [Related]
12. Results of initial operation for hyperparathyroidism in patients with multiple endocrine neoplasia type 1.
Elaraj DM; Skarulis MC; Libutti SK; Norton JA; Bartlett DL; Pingpank JF; Gibril F; Weinstein LS; Jensen RT; Marx SJ; Alexander HR
Surgery; 2003 Dec; 134(6):858-64; discussion 864-5. PubMed ID: 14668715
[TBL] [Abstract][Full Text] [Related]
13. Primary hyperparathyroidism in patients with multiple endocrine neoplasia type 1: Impact of genotype and surgical approach on long-term postoperative outcomes.
Shariq OA; Abrantes VB; Lu LY; Tebben PJ; Foster TM; Dy BM; Lyden ML; Young WF; McKenzie TJ
Surgery; 2024 Jan; 175(1):8-16. PubMed ID: 37891063
[TBL] [Abstract][Full Text] [Related]
14. Total parathyroidectomy in a large cohort of cases with hyperparathyroidism associated with multiple endocrine neoplasia type 1: experience from a single academic center.
Montenegro FL; Lourenço DM; Tavares MR; Arap SS; Nascimento CP; Massoni Neto LM; D'Alessandro A; Toledo RA; Coutinho FL; Brandão LG; de Britto e Silva Filho G; Cordeiro AC; Toledo SP
Clinics (Sao Paulo); 2012; 67 Suppl 1(Suppl 1):131-9. PubMed ID: 22584718
[TBL] [Abstract][Full Text] [Related]
15. Subtotal parathyroidectomy as an adequate treatment for primary hyperparathyroidism in multiple endocrine neoplasia type 1.
Hubbard JG; Sebag F; Maweja S; Henry JF
Arch Surg; 2006 Mar; 141(3):235-9. PubMed ID: 16549687
[TBL] [Abstract][Full Text] [Related]
16. Minimally invasive parathyroidectomy provides a conservative surgical option for multiple endocrine neoplasia type 1-primary hyperparathyroidism.
Versnick M; Popadich A; Sidhu S; Sywak M; Robinson B; Delbridge L
Surgery; 2013 Jul; 154(1):101-5. PubMed ID: 23809488
[TBL] [Abstract][Full Text] [Related]
17. Recurrent hyperparathyroidism and forearm parathyromatosis after total parathyroidectomy.
Melck AL; Carty SE; Seethala RR; Armstrong MJ; Stang MT; Ogilvie JB; Yip L
Surgery; 2010 Oct; 148(4):867-73; discussion 873-5. PubMed ID: 20800255
[TBL] [Abstract][Full Text] [Related]
18. Surgery for multiple endocrine neoplasia type 1-associated primary hyperparathyroidism.
Waldmann J; López CL; Langer P; Rothmund M; Bartsch DK
Br J Surg; 2010 Oct; 97(10):1528-34. PubMed ID: 20629112
[TBL] [Abstract][Full Text] [Related]
19. Impact of "Tailored" Parathyroidectomy for Treatment of Primary Hyperparathyroidism in Patients with Multiple Endocrine Neoplasia Type 1.
Horiuchi K; Sakurai M; Haniu K; Nagai E; Tokumitsu H; Yoshida Y; Omi Y; Sakamoto A; Okamoto T
World J Surg; 2018 Jun; 42(6):1772-1778. PubMed ID: 29138914
[TBL] [Abstract][Full Text] [Related]
20. Total and Subtotal Parathyroidectomy in Young Patients With Multiple Endocrine Neoplasia Type 1-Related Primary Hyperparathyroidism: Potential Post-surgical Benefits and Complications.
Tonelli F; Marini F; Giusti F; Brandi ML
Front Endocrinol (Lausanne); 2018; 9():558. PubMed ID: 30319541
[No Abstract] [Full Text] [Related]
[Next] [New Search]
